Abbott Predicts Arthritis Therapy Humira Will Top $1 Bil. In 2005
Executive Summary
Abbott predicts Humira (adalimumab) sales will top $1 bil. worldwide in 2005
You may also be interested in...
Abbott Will Still Promote Synthroid; Flomax Reps Will Have New Products
Abbott will continue promoting Synthroid despite the recent launch of AB-rated levothyroxine generics
Abbott Will Still Promote Synthroid; Flomax Reps Will Have New Products
Abbott will continue promoting Synthroid despite the recent launch of AB-rated levothyroxine generics
Abbott Sets Hospira Spin-Off For May 3; Market Cap Estimated At $5 Bil.
Abbott Labs will complete the spin-off of its hospital products business Hospira on May 3